Serhat Gürbüz | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Serhat Gürbüz | Clinical Medicine | Best Researcher Award 

Doctor of Medicine | University of Health Sciences | Turkey

Dr. Serhat Gürbüz, MD, MSc, is a distinguished Consultant in Orthopedics and Traumatology at the Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. His professional expertise centers on knee, shoulder, and sports surgery, integrating advanced arthroscopic techniques and evidence-based rehabilitation strategies to restore function and improve patient outcomes. Dr. Gürbüz has contributed substantially to the field through scholarly publications in reputable peer-reviewed and indexed journals, clinical presentations, and collaborative research projects focused on musculoskeletal disorders and joint preservation. His work demonstrates a commitment to combining clinical excellence with translational research, contributing to the evolution of orthopedic surgical standards and innovations in minimally invasive procedures. He has maintained active collaborations with national and international orthopedic research groups and serves as a peer reviewer and academic contributor within the global orthopedic community. Dr. Gürbüz’s clinical practice reflects a deep dedication to advancing patient-centered care, surgical innovation, and academic mentorship, fostering the development of future orthopedic specialists. His academic engagement and research productivity underscore his contribution to scientific knowledge dissemination and the enhancement of evidence-based orthopedic medicine. Through his multidisciplinary collaborations and continuous pursuit of clinical innovation, Dr. Gürbüz has strengthened the bridge between medical research and practical application, ultimately promoting better musculoskeletal health and improving the quality of life for patients across diverse populations. He has 6 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Çelikoyar, M. M., Topsakal, O., & Gürbüz, S. (2019). Mobile technology for recording surgical procedures. Journal of Visual Communication in Medicine.

2. Imren, Y., Karslioglu, B., Dedeoglu, S. S., Cabuk, H., Atar, S., Gürbüz, S., … (2021). The effect of gluteus maximus tenotomy in primary total hip arthroplasty with posterior approach: Kinematic analysis of hip extensor strength. Journal of Orthopaedic Surgery.

3. Yüce, A., Yerli, M., Erkurt, N., Gürbüz, S., Çakar, M., & Adaş, M. (2022). Neutrophil-lymphocyte and C-reactive protein–albumin ratios as predictors of re-surgery in adult native knee septic arthritis. Journal of Clinical and Investigative Surgery.

4. Gürbüz, S., Bahar, H., Yavuz, U., Keskin, A., Karslioglu, B., & Solak, Y. (2025). Comparative efficacy of ChatGPT and DeepSeek in addressing patient queries on gonarthrosis and total knee arthroplasty. Arthroplasty Today.

5. Gürbüz, S., Ocak, O., Kir, M. C., Karslioglu, B., & Aki, S. (2025). Hyperchloremia at hospital admission for hip fractures is related with an increase in morbidity and mortality rates. Turkish Journal of Trauma and Emergency Surgery.

Dr. Serhat Gürbüz’s work advances global orthopedic science through innovative surgical techniques, evidence-based clinical research, and multidisciplinary collaborations that enhance musculoskeletal health. His commitment to patient-centered innovation and translational research contributes significantly to improving mobility, recovery, and quality of life in society worldwide.

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.